Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?

To: Dataminer1 who wrote (333)	7/13/1999 2:17:00 PM
From: sim1	Read Replies (1) \| Respond to of 422

Some minor press exposure... from today's "The Real 'Most Active'" section of IBD. Immucor, which makes and sells blood testing reagents and sytems gained 1 1/2 to a 52-week high of 16 3/8 on high volume. The stock is still 36% off its October 1991 record high of 26. In late May, Immucor said it had reached a milestone run rate of 1 million tests per month on its blood-bank automation systems. Looks like it will make that section in tomorrow's paper as well.

To: Dataminer1 who wrote (333)	8/1/1999 9:39:00 AM
From: Thomas Kirwin	Respond to of 422

R&A Fast Fact #6 - Market Size/Share "We estimate the potential market for all three instruments at $446.8 million, with an annual reagent trail of $210.5 million. Obtaining even a 10% share of that market would more than double Immucor's current annual volume. We believe the company can achieve that goal over the next two to three years, substantially expanding its base of sales and earnings, and solidifying its competitive position" Best O'Luck Tom

To: Dataminer1 who wrote (333)	8/22/1999 10:57:00 AM
From: Thomas Kirwin	Read Replies (1) \| Respond to of 422

NEW Immucor (BLUD) Due-Diligence Site Available For Interested Investors! Immucor (BLUD) now has its own club offering great links, photos of reports, news items, analysts reports (coming soon) and a very comprehensive calendar of events. The stock has appreciated 21.7% in the last 3 Months, 76.71% - 6 Months, and 89.71% - YTD based on earnings and growth rates alone. A new b2b e-Commerce product for blood labs and hospitals is scheduled to be launched shortly. Simply follow this link to preview the BLUD Club site. Feel free to add your comments regarding Immucor as an investment. clubs.yahoo.com Best O'Luck! Tom